000 | 01941 a2200517 4500 | ||
---|---|---|---|
005 | 20250516013443.0 | ||
264 | 0 | _c20111227 | |
008 | 201112s 0 0 eng d | ||
022 | _a1879-1379 | ||
024 | 7 |
_a10.1016/j.jpsychires.2010.11.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCrespo-Facorro, Benedicto | |
245 | 0 | 0 |
_aRelapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. _h[electronic resource] |
260 |
_bJournal of psychiatric research _cJun 2011 |
||
300 |
_a763-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBenzodiazepines _xtherapeutic use |
650 | 0 | 4 | _aDiagnostic and Statistical Manual of Mental Disorders |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHaloperidol _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOlanzapine |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aPsychiatric Status Rating Scales |
650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
650 | 0 | 4 |
_aRisperidone _xtherapeutic use |
650 | 0 | 4 | _aSecondary Prevention |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aPérez-Iglesias, Rocío | |
700 | 1 | _aMata, Ignacio | |
700 | 1 | _aCaseiro, Olalla | |
700 | 1 | _aMartínez-Garcia, Obdulia | |
700 | 1 | _aPardo, Gema | |
700 | 1 | _aRamirez-Bonilla, Mariluz | |
700 | 1 | _aPelayo-Terán, Jose Maria | |
700 | 1 | _aVázquez-Barquero, José L | |
773 | 0 |
_tJournal of psychiatric research _gvol. 45 _gno. 6 _gp. 763-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpsychires.2010.11.002 _zAvailable from publisher's website |
999 |
_c20399370 _d20399370 |